Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptions

Halozyme Therapeutics, Inc. News

Biotechs Weakened by The Stock Market Rout

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Who Will Survive?: Cramer's 'Mad Money' Recap (Thursday 5/14/20)

Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

It's Bad, But It's Not a Crash: Cramer's 'Mad Money' Recap

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Shopify, Kinder Morgan, Pfizer: 'Mad Money' Lightning Round

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Roku, Sierra Wireless, Visa, Cimarex Energy: 'Mad Money' Lightning Round

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

Breaking News

Gap Stock Slumps On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.